Piperacillin + Tazobactam Intravenous (Iv) Injection/Infusion Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection/Infusion

Available Strengths: 2.25 g (2 g Piperacillin + 0.25 g Tazobactam); 3.375 g(3+3.75g); 4.5g(4+0.5g)

Reference Brands: Zosyn(US); Tazocin(EU)

Category: Critical Care

Piperacillin + Tazobactam Intravenous (IV) Injection/Infusion is available in Intravenous (IV) Injection/Infusion and strengths such as 2.25 g (2 g Piperacillin + 0.25 g Tazobactam); 3.375 g(3+3.75g); 4.5g(4+0.5g). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Piperacillin + Tazobactam Intravenous (IV) Injection/Infusion is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Piperacillin + Tazobactam Intravenous (IV) Injection/Infusion can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Piperacillin + Tazobactam is a widely used broad-spectrum β-lactam/β-lactamase inhibitor combination antibiotic effective against a range of serious infections, including hospital-acquired pneumonia, intra-abdominal infections, and sepsis. It is administered intravenously and comes in 2.25 g, 3.375 g, and 4.5 g strengths, supplied as vials or ready-to-use infusions. In the US, it is marketed as Zosyn by Pfizer and through generics by Hikma, Fresenius, and Sandoz. In the EU, it’s sold as Tazocin and other branded generics. Piperacillin/Tazobactam is a key product on pharma B2B platforms, ensuring efficient procurement for hospitals, ICUs, and surgical departments.